Truist Securities Reiterates Hold on Zimmer Biomet Holdings, Lowers Price Target to $92

Benzinga Newsdesk www.benzinga.com Negative 88.1%

Neg 88.1% Neu 0% Pos 0%

Truist Securities analyst Richard Newitter reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price target from $98 to $92.